https://investor.ironwoodpharma.com/press-releases/press-release-details/2016/Ironwood-Pharmaceuticals-Announces-Filing-by-Astellas-of-New-Drug-Application-in-Japan-with-Linaclotide-for-the-Treatment-of-Adults-with-IBS-C/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- February 24, 2016